Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
The Journal of Applied Instructional Design|July 3, 2026
Bridging Silos: Collaborating to Create Authentic Learning Experiences for Future Instructional DesignersS L Gronseth, A Itani, B M Beech, et al.Proceedings of the National Academy of Sciences of the United States of America|May 9, 2007
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesGamal A Elmowalid, Ming Qiao, Sook-Hyang Jeong, et al.European Journal of Physical and Rehabilitation Medicine|June 18, 2024
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxinMarco Battaglia, Margherita B Borg, Alberto Loro, et al.Journal of the American Chemical Society|March 12, 2016
Amyloid-β and α-Synuclein Decrease the Level of Metal-Catalyzed Reactive Oxygen Species by Radical Scavenging and Redox SilencingJeppe T Pedersen, Serene W Chen, Christian B Borg, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 23, 2011
Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosisBrian B Borg, Anil Seetharam, Vijay Subramanian, et al.Alimentary Pharmacology & Therapeutics|October 24, 2008
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitisR Loomba, G Lutchman, D E Kleiner, et al.Protein Science : a Publication of the Protein Society|December 27, 2025
Role of N-glycosylation as a determinant of ATG9A conformations and activityMattia Utichi, Matteo Lambrughi, Henri-Baptiste Marjault, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 2020
Mechanism and site of action of big dynorphin on ASIC1aChristian B Borg, Nina Braun, Stephanie A Heusser, et al.Alimentary Pharmacology & Therapeutics|February 19, 2010
Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine responseY Rotman, B B Borg, A Soza, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2009
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppressionTara N Palmore, Neeral L Shah, Rohit Loomba, et al.Pageof 9